Compliance interview prep.

Senior PE compliance coach, a CCO or deputy CCO at a private-fund adviser running a buyout strategy.

What interviewers look for

  • Does the candidate frame compliance as a risk-based programme designed for a deal-driven culture, control + surveil + investigate + escalate + document, not just 'I know Rule 206(4)-7'?
  • Can they walk the PE-distinctive MNPI mechanic front-to-back, board-seat info, restricted list across deal pipeline + portfolio companies, wall-crossings, cleansing, with the deal partner + GC escalation paths named?
  • Do they understand Code of Ethics + Rule 204A-1 in a deal-team context, pre-clearance, blackout, restricted list, IPO / private-placement carve-outs (Rule 5130 / 5131), without becoming the deal team's adversary?
  • Are they fluent on Marketing Rule (Rule 206(4)-1) applied to private-fund marketing, track record + performance presentation, hypothetical performance, testimonials + endorsements, placement-agent disclosures?
  • Do they get the LP disclosure + side-letter + MFN mechanic. ILPA Principles, ADV Part 2A conflict disclosure, fee + expense allocation between fund + portfolio company?
  • Do they have an evidence + documentation instinct, every wall-cross logged, every restricted-list change timestamped, every marketing claim substantiated at the time of statement?

Behavioural questions to expect

  1. Walk me through your CV.

    What it tests: Story coherence + deliberate PE / private-fund compliance trajectory. The interviewer wants evidence of a control + fiduciary + investigation mindset PLUS comfort in a deal-driven culture, not a candidate who washed into compliance from a back-office role and can't speak the deal team's language.

  2. Tell me about a project where you owned a compliance review, control gap, or regulatory response end-to-end.

    What it tests: Whether the candidate thinks like an operator under the rules: a real issue with a specific risk, structured investigation, escalation decision, documented remediation, not 'I reviewed personal trades'. Tests ownership + judgment + documentation discipline in a deal-driven culture.

  3. Tell me about a weakness, a failure, or feedback you've received and worked on.

    What it tests: Self-awareness + judgment discipline. Cross-role canonical. In PE compliance, the costly failure is escalating too late, being too quick to clear, being inflexible against the deal team when a risk-based call was needed, or losing the deal partner's trust by being a watchdog rather than a partner.

  4. Why PE buyout compliance, why not long-only AM, hedge-fund, banking compliance, or the legal side?

    What it tests: Authentic fit for a PE compliance seat: comfort in a deal-driven culture, fluency with the distinctive PE risks (board-seat MNPI, deal-team personal trading, fundraise marketing), willingness to be a partner to the deal team rather than a back-office watchdog.

  5. Within PE compliance, deal-pipeline / MNPI, fundraise + marketing review, Code of Ethics + personal trading, or regulatory reporting + LP disclosure, which seat appeals, and why?

    What it tests: Whether the candidate understands the sub-functions of a PE compliance programme and has a self-aware preference. Deal-pipeline = restricted list + wall-crossings + cleansing across portfolio + pipeline; fundraise = Marketing Rule + placement-agent + pitchbook review; CoE = pre-clearance + 204A-1 + IPO / private-placement allocations; reg reporting = Form PF + Form ADV + 13D + ILPA reporting + AIFMD Annex IV.

  6. Why this firm?

    What it tests: Whether the candidate has done the homework. Bar: firm-specific evidence on regulatory profile, fund family, programme leadership, recent regulatory programmes, not generic 'strong reputation'.

  7. How would you describe this firm's compliance programme and where you'd add value?

    What it tests: Whether the candidate has internalised HOW the firm's compliance programme operates, its regulatory scope, fund family, leadership, surveillance + monitoring approach, not just that the firm 'has a compliance team'.

  8. What recent regulatory programme or change has affected this firm's compliance function, and how would you have approached it?

    What it tests: Whether the candidate follows the private-fund regulatory agenda. SEC Marketing Rule (Nov 2022), Form PF 2024 amendments (current-reporting events), vacated Private Fund Advisers Rule (still an exam priority for fees / expense allocation / preferential treatment), SFDR (Jan 2023 Level 2), AIFMD II, and can frame the operational implications for a PE buyout adviser.

Technical concepts to master

Code of Ethics + personal trading (Rule 204A-1), deal-team application

Access-person definition (deal team)
Under Rule 204A-1, deal-team associates, VPs, principals, MDs, IC members, and operating partners are access persons (access to non-public deal pipeline + portfolio holdings); back-office IT staff without holdings access typically are not.
Restricted list across pipeline + portfolio
Restricted list in a PE shop combines: (a) active deal pipeline names under diligence; (b) portfolio companies (especially public ones); (c) competitors / customers / suppliers of pipeline + portfolio where MNPI may flow.
Pre-clearance + blackout (deal team)
Deal-team personal trades require pre-clearance; default DENY for any name on the restricted list; common carve-outs: broad-based ETFs, govt securities, open-end mutual funds (non-affiliated).
IPO + private-placement allocations (Rule 5130 / 5131)
FINRA Rule 5130 prohibits broker-dealer-affiliated 'restricted persons' from receiving IPO allocations; Rule 5131 prohibits IPO allocations in exchange for future investment-banking business (spinning).

SEC Marketing Rule (Rule 206(4)-1), private-fund application

General prohibitions (7-part)
Seven general prohibitions covering untrue + unsubstantiated material statements, misleading implications, unfair + unbalanced benefit-vs-risk treatment, biased specific investment advice, misleading inclusion or exclusion of performance, and otherwise materially misleading content.
Performance presentation, track record
Net of fees + carry alongside gross; consistent calculation methodology (DPI, RVPI, TVPI, IRR) disclosed; vintage methodology defined; benchmark (third-party benchmark Associates, Preqin, Burgiss) cited.
Hypothetical performance
Back-tested, model, projected, or target return performance has specific extra disclosure burdens; allowed only to recipients for whom it is relevant, with policies + procedures designed to that audience.
Testimonials + endorsements + placement agents
Testimonials (from LPs) + endorsements (from non-LPs) allowed with: clear + prominent disclosure of relationship + compensation + conflicts; written agreement; oversight; disqualification provisions; placement agents fall within scope.

MNPI + restricted list + board-seat mechanics (PE-distinctive)

MNPI definition + materiality framing
Material = information a reasonable investor would consider important to an investment decision; non-public = not yet disseminated to the public via filing, press release, or wide channel.
Restricted list mechanics (PE)
Combines: (a) active deal pipeline; (b) portfolio companies (especially public); (c) sector-adjacent names where MNPI may flow. Monitored at trading layer; updated as deals close + wall-cross + cleanse.
Board-seat info flow + board-pack distribution
Deal partners + operating partners on portfolio boards receive MNPI via board packs + board meetings + management calls; board-pack distribution lists must be controlled; board-observer protocols apply.
Wall-crossings + cleansing
Wall-crossing = a documented, pre-approved process to bring a public-side person over the wall for a specific deal / engagement; cleansing = removal of restriction when MNPI becomes public or stale.

ILPA Principles + side letters + LP disclosure

ILPA Principles + Reporting Template + DDQ
ILPA Principles 3.0 set LP expectations on alignment of interests, governance, transparency; ILPA Quarterly Reporting Standard standardises capital-call + distribution notice + financial reporting; ILPA DDQ standardises LP diligence questions.
Side-letter terms + categories
Side letters grant LPs preferential terms across categories: economic (fee, carry, expense), governance (advisory-committee seat, key-person consent), informational (enhanced reporting, transparency), protective (MFN, regulatory carve-outs, ESG opt-outs).
MFN (Most-Favoured Nation) mechanic
MFN clause gives an LP the right to elect into preferential terms granted to later-fund LPs (same fund or successor fund, depending on drafting); operational implementation requires a side-letter circulation process within a defined window.
Conflict + preferential-term disclosure (Form ADV Part 2A)
Form ADV Part 2A requires plain-English disclosure of conflicts of interest, fees + expense allocation methodologies, side-letter practice, and material preferential terms.

Practical drills

  • A deal partner sits on the board of a public portfolio company and receives a board pack the night before a board meeting showing an unannounced earnings miss + capex cut. The same partner is sourcing a new investment in a sector-adjacent competitor. The board meeting is tomorrow; earnings release is in 10 days. Walk me through how you'd handle it.
  • The IR team submits a draft Fund VIII pitchbook. It includes: (a) 'Top-quartile DPI across Funds V, VI, VII vs third-party benchmark Associates Buyout benchmark'; (b) a chart showing MoM + IRR by vintage net of fees + carry; (c) a hypothetical illustration 'Illustrative Fund VIII returns assuming entry multiples 5% below current public comps'; (d) a quote from a Tier-1 institutional LP calling the team 'best-in-class capital deployers'. Walk me through your review.
  • A deal-team associate (covers consumer + retail sector) submits a pre-clearance request to buy 500 shares of a public consumer name at ~$80 ($40k position). The firm is in advanced diligence on a take-private of a smaller competitor in the same sector. The public name itself is not the target, but the diligence data room includes customer + supplier overlap analysis referencing the public name. The firm's blackout window is 30 days before + after firm trading; the de-minimis exemption is < 0.01% of issuer market cap (this issuer is $4bn cap, so 0.01% = $400k). Walk me through your decision.

Smart-question anchors

  • Programme structure + leadership - CCO reporting line, deputy structure, three-lines-of-defence relationships
  • Regulatory agenda - Marketing Rule, Form PF 2024 amendments, ILPA alignment, SFDR, AIFMD II implementation
  • Deal-pipeline + board-seat policy - restricted list mechanics, wall-crossings, board-pack distribution discipline
  • Code of Ethics + deal-team personal trading - blackout mechanics, IPO carve-outs, recent exception trends
  • LP disclosure + side-letter + MFN process - election register, tracking discipline, ADV Part 2A practice

Related roles

Sourced from

Ready to Generate Your Own Prep?

Drop your CV and a job description on the home page. A couple of minutes later you get a report with everything you need to land the job.